Iradimed (IRMD) Gains from Sales and Divestitures (2017 - 2025)
Iradimed (IRMD) reported Gains from Sales and Divestitures of $63105.0 for Q4 2025, up 23.57% year-over-year from $51069.0 in Q4 2024, and up 23.57% on a QoQ basis from $51069.0 in Q4 2024.
Iradimed (IRMD) has 9 years of Gains from Sales and Divestitures data on file, last reported at $63105.0 in Q4 2025.
- Quarterly Gains from Sales and Divestitures rose 23.57% year-over-year to $63105.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $63105.0 (up 23.57% YoY) and the FY2025 annual result came in at $63105.0, up 23.57% from the prior year.
- Gains from Sales and Divestitures improved to $63105.0 in Q4 2025 per IRMD's latest filing, from $51069.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $63105.0 in Q4 2025 and bottomed at $4252.0 in Q4 2023.
- The 5-year median for Gains from Sales and Divestitures is $51069.0 (2024), against an average of $43566.8.
- The widest annual swing landed in 2023, when Gains from Sales and Divestitures sank 89.57%; it then surged 1101.06% in 2024.
- Tracing IRMD's Gains from Sales and Divestitures over 5 years: stood at $58650.0 in 2021, then plunged by 30.51% to $40758.0 in 2022, then slumped by 89.57% to $4252.0 in 2023, then surged by 1101.06% to $51069.0 in 2024, then advanced by 23.57% to $63105.0 in 2025.
- Per Business Quant, the three latest IRMD Gains from Sales and Divestitures figures stand at $63105.0 (Q4 2025), $51069.0 (Q4 2024), and $4252.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63,105.00 |
| Dec 31, 2025 | 63,105.00 |
| Dec 31, 2024 | 51,069.00 |
| Dec 31, 2024 | 51,069.00 |
| Dec 31, 2023 | 4,252.00 |
| Dec 31, 2023 | 4,252.00 |
| Dec 31, 2022 | 40,758.00 |
| Dec 31, 2022 | 40,758.00 |
| Dec 31, 2021 | 58,650.00 |
| Dec 31, 2021 | 58,650.00 |
| Dec 31, 2020 | 9,345.00 |
| Dec 31, 2020 | 9,345.00 |
| Sep 30, 2020 | 139,890.00 |
| Sep 30, 2020 | 139,890.00 |
| Jun 30, 2020 | 128,878.00 |
| Jun 30, 2020 | 128,878.00 |
| Mar 31, 2020 | 19,844.00 |
| Mar 31, 2020 | 19,844.00 |
| Dec 31, 2019 | 93,989.00 |
| Dec 31, 2019 | 93,989.00 |
| Sep 30, 2019 | 33,144.00 |
| Sep 30, 2019 | 33,144.00 |
| Jun 30, 2019 | 32,964.00 |
| Jun 30, 2019 | 32,964.00 |
| Mar 31, 2019 | 5,200.00 |
| Mar 31, 2019 | 5,200.00 |
| Dec 31, 2018 | 89,457.00 |
| Dec 31, 2018 | 89,457.00 |
| Sep 30, 2018 | 23,695.00 |
| Sep 30, 2018 | 23,695.00 |
| Jun 30, 2018 | 23,582.00 |
| Jun 30, 2018 | 23,582.00 |
| Mar 31, 2018 | 3,452.00 |
| Mar 31, 2018 | 3,452.00 |
| Dec 31, 2017 | 62,665.00 |
| Dec 31, 2017 | 62,665.00 |
| Sep 30, 2017 | 20,224.00 |
| Sep 30, 2017 | 20,224.00 |
| Jun 30, 2017 | 20,112.00 |
| Jun 30, 2017 | 20,112.00 |
| Mar 31, 2017 | 17,396.00 |
| Mar 31, 2017 | 17,396.00 |